Literature DB >> 12138302

Autonomic dysfunction in multiple sclerosis: correlation with disease-related parameters.

Dilek I Gunal1, Nazire Afsar, Tulin Tanridag, Sevinc Aktan.   

Abstract

Cardiovascular autonomic functions were investigated in a prospective, controlled study of 22 consecutive relapsing-remitting multiple sclerosis (MS) patients and 22 healthy subjects using 5 simple noninvasive tests and sympathetic skin response testing. Tests included the heart rate response to deep breathing, valsalva maneuver and standing, blood pressure response to standing and sustained hand grip, and were graded according to the Ewing and Clark classification as early, definite or severe impairment. The relationship between autonomic dysfunction and disease-related parameters such as the expanded disability status scale (EDSS) and disease duration was studied. Ninety percent of the patients had symptoms related with autonomic dysfunction, and 45.5 % had abnormal results in cardiovascular autonomic function testing with 4 patients also having abnormal sympathetic skin responses. Statistical analysis indicated that patients with a long disease duration rather than high EDSS carried a risk of autonomic involvement in MS. Both parasympathetic and sympathetic functions were impaired and this could have been easily overlooked by a standard EDSS follow-up. In this regard, autonomic function testing seems necessary in order to detect subclinical changes in MS patients and should be considered in outcome measures. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12138302     DOI: 10.1159/000064949

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  19 in total

Review 1.  Immune and autonomic nervous system interactions in multiple sclerosis: clinical implications.

Authors:  Mario Habek
Journal:  Clin Auton Res       Date:  2019-04-08       Impact factor: 4.435

2.  Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.

Authors:  Simona Petrescu; Raluca Trifanescu; Petru Ionescu; Gina Doinita Vanghelie; Radu Tanasescu; Mircea Moldovan; Nicolae Munjev; Ovidiu Bajenaru; Cristina Panea
Journal:  Maedica (Bucur)       Date:  2013-03

3.  Difficulties in the diagnosis of autonomic dysfunction in multiple sclerosis.

Authors:  Beata Labuz-Roszak; Krystyna Pierzchala
Journal:  Clin Auton Res       Date:  2007-10-19       Impact factor: 4.435

Review 4.  Impact of the Autonomic Nervous System on the Skeleton.

Authors:  Florent Elefteriou
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

5.  Depression and Age at First Neurology Appointment Associated with Receipt of Behavioral Medicine Services Within 1 Year in a Multiple Sclerosis Population.

Authors:  Benjamin Greenberg; Youran Fan; Lucille Carriere; Amy Sullivan
Journal:  Int J MS Care       Date:  2017 Jul-Aug

6.  The presence of dysautonomia in different subgroups of myasthenia gravis patients.

Authors:  Ana Nikolić; Stojan Perić; Tanja Nišić; Srdjan Popović; Miroljub Ilić; Vidosava Rakočević Stojanović; Dragana Lavrnić
Journal:  J Neurol       Date:  2014-08-14       Impact factor: 4.849

7.  I-123 MIBG cardiac scintigraphy and autonomic test evaluation in multiple sclerosis patients.

Authors:  Mordechai Lorberboym; Yair Lampl; Galina Nikolov; Menachem Sadeh; Ronit Gilad
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

Review 8.  Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.

Authors:  Zohara Sternberg
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

Review 9.  Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis.

Authors:  Zohara Sternberg
Journal:  Neuromolecular Med       Date:  2015-10-26       Impact factor: 3.843

10.  Assessment of autonomic nervous system dysfunction in multiple sclerosis and association with clinical disability.

Authors:  Nilufer Kale; Setty Magana; Jale Agaoglu; Osman Tanik
Journal:  Neurol Int       Date:  2009-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.